Publications

Year of Publicationsort ascending Title Faculty Association
2015 The mixed-action delta/mu opioid agonist MMP-2200 does not produce conditioned place preference but does maintain drug self-administration in rats, and induces in vitro markers of tolerance and dependence. John M. Streicher, PhD
2015 Blockade of non-opioid excitatory effects of spinal dynorphin A at bradykinin receptors. Frank Porreca, PhD, Todd Vanderah, PhD
2015 Impact of Type 2 Diabetes and Postmenopausal Hormone Therapy on Incidence of Cognitive Impairment in Older Women. Roberta Diaz Brinton, Ph.D
2015 Discovery of 5-substituted tetrahydronaphthalen-2yl-methyl with N-phenyl-N-(piperidin-4-yl)propionamide derivatives as potent opioid receptor ligands. Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD
2015 Therapeutic potential of peroxynitrite decomposition catalysts: a patent review. Todd Vanderah, PhD
2015 Targeting the prodromal stage of Alzheimer's disease: bioenergetic and mitochondrial opportunities. Roberta Diaz Brinton, Ph.D
2015 Epigenetic Regulation of GDF2 Suppresses Anoikis in Ovarian and Breast Epithelia. Nam Lee, Ph.D.
2015 White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease. Roberta Diaz Brinton, Ph.D, Fei Yin, Ph.D.
2015 Gemcitabine resistant pancreatic cancer cell lines acquire an invasive phenotype with collateral hypersensitivity to histone deacetylase inhibitors.
2015 Design and synthesis of novel bivalent ligands (MOR and DOR) by conjugation of enkephalin analogues with 4-anilidopiperidine derivatives. Victor Hruby, Ph.D., Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD
2014 Capsaicin-responsive corneal afferents do not contain TRPV1 at their central terminals in trigeminal nucleus caudalis in rats. Tally Largent-Milnes, PhD
2014 Discovery of amphipathic dynorphin A analogues to inhibit the neuroexcitatory effects of dynorphin A through bradykinin receptors in the spinal cord. Victor Hruby, Ph.D., Josephine Lai , Ph.D., Frank Porreca, PhD, Todd Vanderah, PhD
2014 Estrogen: a master regulator of bioenergetic systems in the brain and body. Roberta Diaz Brinton, Ph.D
2014 Synthesis and evaluation of bivalent ligands for binding to the human melanocortin-4 receptor.
2014 External QX-314 inhibits evoked cranial primary afferent synaptic transmission independent of TRPV1. Tally Largent-Milnes, PhD
2014 Animal models for opioid addiction drug discovery. Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2014 Reversal of metabolic deficits by lipoic acid in a triple transgenic mouse model of Alzheimer's disease: a 13C NMR study. Roberta Diaz Brinton, Ph.D
2014 Behavioral and cellular pharmacology characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan (NAQ) as a mu opioid receptor selective ligand. John M. Streicher, PhD
2014 Drug delivery to the ischemic brain. Patrick T Ronaldson, PhD, FAAPS
2014 Hypermetabolic state in the 7-month-old triple transgenic mouse model of Alzheimer's disease and the effect of lipoic acid: a 13C-NMR study. Roberta Diaz Brinton, Ph.D
2014 Immortalization of normal human mammary epithelial cells in two steps by direct targeting of senescence barriers does not require gross genomic alterations.
2014 Differential regulation of collapsin response mediator protein 2 (CRMP2) phosphorylation by GSK3ß and CDK5 following traumatic brain injury.
2014 Intranasal drug delivery to the brain Jeffrey J. Lochhead, PhD
2014 Antibody-directed coupling of endoglin and MMP-14 is a key mechanism for endoglin shedding and deregulation of TGF-β signaling. Nam Lee, Ph.D.
2014 Hypoxia/reoxygenation stress signals an increase in organic anion transporting polypeptide 1a4 (Oatp1a4) at the blood-brain barrier: relevance to CNS drug delivery. Patrick T Ronaldson, PhD, FAAPS

Pages